Evaluation of Oxidative Metabolism in Child and Adolescent Patients with Attention Deficit Hyperactivity Disorder
- PMID: 26207130
- PMCID: PMC4504919
- DOI: 10.4306/pi.2015.12.3.361
Evaluation of Oxidative Metabolism in Child and Adolescent Patients with Attention Deficit Hyperactivity Disorder
Abstract
Objective: Oxidative metabolism is impaired in several medical conditions including psychiatric disorders, and this imbalance may be involved in the etiology of these diseases. The present study evaluated oxidative balance in pediatric and adolescent patients with attention deficit hyperactivity disorder (ADHD).
Methods: The study included 48 children and adolescents (34 male, 14 female) with ADHD who had no neurological, systemic, or comorbid psychiatric disorders, with the exception of oppositional defiant disorder (ODD), and 24 sex- and age-matched healthy controls (17 male and seven female).
Results: TAS was significantly lower, and TOS and OSI were significantly higher in patients with ADHD than in healthy controls. Total antioxidant levels were lower in patients with comorbid ODD than in those with no comorbidity. No difference was found in TOS or OSI among the ADHD subtypes; however, TAS was higher in the attention-deficient subtype.
Conclusion: Our findings demonstrated that oxidative balance is impaired and oxidative stress is increased in children and adolescents with ADHD. This results are consistent with those of previous studies.
Keywords: Attention deficit hyperactivity disorder; Child and adolescent; Oxidative imbalance; Oxidative stress; Total antioxidant status; Total oxidant status.
Similar articles
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications.J Psychiatr Res. 2012 Apr;46(4):451-5. doi: 10.1016/j.jpsychires.2011.12.007. Epub 2012 Jan 17. J Psychiatr Res. 2012. PMID: 22257388
-
Increased oxidative stress in children with attention deficit hyperactivity disorder.Redox Rep. 2016 Nov;21(6):248-53. doi: 10.1080/13510002.2015.1116729. Epub 2016 Feb 18. Redox Rep. 2016. PMID: 26886057 Free PMC article.
-
The Psychosocial Outcome of Conduct and Oppositional Defiant Disorder in Children With Attention Deficit Hyperactivity Disorder.Cureus. 2020 Aug 2;12(8):e9521. doi: 10.7759/cureus.9521. Cureus. 2020. PMID: 32905151 Free PMC article. Review.
-
[Impact of comorbidity on the executive function of patients with attention deficit hyperactivity disorder (review)].Beijing Da Xue Xue Bao Yi Xue Ban. 2007 Jun 18;39(3):329-32. Beijing Da Xue Xue Bao Yi Xue Ban. 2007. PMID: 17572794 Review. Chinese.
Cited by
-
Changes in Cortisol and in Oxidative/Nitrosative Stress Indicators after ADHD Treatment.Antioxidants (Basel). 2024 Jan 12;13(1):92. doi: 10.3390/antiox13010092. Antioxidants (Basel). 2024. PMID: 38247516 Free PMC article.
-
Effect of Vitamin D on Paraxonase-1, Total Antioxidant Capacity, and 8-Isoprostan in Children with Attention Deficit Hyperactivity Disorder.Int J Clin Pract. 2022 Jan 31;2022:4836731. doi: 10.1155/2022/4836731. eCollection 2022. Int J Clin Pract. 2022. PMID: 35685610 Free PMC article. Clinical Trial.
-
Attention deficit-hyperactivity disorder suffers from mitochondrial dysfunction.BBA Clin. 2016 Oct 18;6:153-158. doi: 10.1016/j.bbacli.2016.10.003. eCollection 2016 Dec. BBA Clin. 2016. PMID: 27896136 Free PMC article.
-
Role of Oxidative Stress and Neuroinflammation in Attention-Deficit/Hyperactivity Disorder.Antioxidants (Basel). 2020 Oct 23;9(11):1039. doi: 10.3390/antiox9111039. Antioxidants (Basel). 2020. PMID: 33114154 Free PMC article. Review.
-
The Effect of Drug Use, Body Mass Index and Blood Pressure on Oxidative Stress Levels in Children and Adolescents with Attention Deficit and Hyperactivity Disorder.Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):88-98. doi: 10.9758/cpn.2023.21.1.88. Clin Psychopharmacol Neurosci. 2023. PMID: 36700315 Free PMC article.
References
-
- Lee SY, Lee SJ, Han C, Patkar AA, Masand PS, Pae CU. Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2013;46:224–235. - PubMed
-
- Pae CU, Paik IH, Lee C, Lee SJ, Kim JJ, Lee CU. Decreased plasma antioxidants in schizophrenia. Neuropsychobiology. 2004;50:54–56. - PubMed
-
- Pae CU, Yu HS, Kim JJ, Lee CU, Lee SJ, Jun TY, et al. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. Int J Neuropsychopharmacol. 2004;7:495–500. - PubMed
-
- Haddad JJ. Oxygen sensing and oxidant/redox-related pathways. Biochem Biophys Res Commun. 2004;316:969–977. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical